Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies

NCT02961101 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Malignancies Multiple

Interventions

DRUG: Anti-PD-1 antibody
DRUG: Decitabine
DRUG: Chemotherapy

Sponsor

Han weidong